Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

4.1K
4.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Stem Cell Culture01:17

Stem Cell Culture

6.7K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial Synthesis of Daphnetin by Engineering 2-Oxoglutarate-Dependent Dioxygenases.

ACS synthetic biology·2026
Same author

Learning induces activation-mechanism-dependent neural plasticity in an intracortical microstimulation task.

bioRxiv : the preprint server for biology·2026
Same author

An innovative germination-driven LAB fermentation strategy for allergenicity reduction in soymilk gels through spatiotemporal protease-mediated epitope disruption.

Food & function·2026
Same author

Bioactive Seed Coating with Chitosan-Salicylic Acid Networks Activates Folate Metabolism and Nutritional Fortification in Wheat Seedlings.

Journal of agricultural and food chemistry·2026
Same author

An Immune Model Incorporating NK Cells and IL-12 to Predict the Efficacy of the Initial Treatment Cycle of Efgartigimod in Generalized Myasthenia Gravis.

Drug design, development and therapy·2026
Same author

CD11c+ CD8 T cells cause IFN-γ-dependent autoimmune neuroinflammation that is restrained by PD-1 signaling.

JCI insight·2026

Related Experiment Video

Updated: Apr 16, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.3K

Induced Stem Cells as a Novel Multiple Sclerosis Therapy.

Chong Xie, Yan-Qun Liu, Yang-Tai Guan1

  • 1Department of Neurology, Changhai Hospital, Second Military Medical University, Shanghai, China. yangtaiguan@hotmail.com.

Current Stem Cell Research & Therapy
|March 4, 2015
PubMed
Summary

Induced pluripotent stem cells (iPSCs) and other induced stem cells show promise for treating multiple sclerosis (MS) by promoting remyelination and improving function. These advanced cell therapies offer new hope for this central nervous system disorder.

More Related Videos

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

16.2K
Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.8K

Related Experiment Videos

Last Updated: Apr 16, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.3K
Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
13:58

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

16.2K
Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.8K

Area of Science:

  • Regenerative Medicine
  • Neuroscience
  • Immunology

Background:

  • Multiple sclerosis (MS) is a debilitating inflammatory demyelinating disease of the central nervous system with limited therapeutic options.
  • Stem cell transplantation, including neural stem cells and mesenchymal stem cells, is being explored for MS due to their regenerative and immunomodulatory potential.

Purpose of the Study:

  • To review recent advancements in stem cell therapy for MS, focusing on induced stem/progenitor cells.
  • To highlight the therapeutic potential of induced pluripotent stem cells (iPSCs), induced neural stem cells (iNSCs), and induced oligodendrocyte progenitor cells (iOPCs) in MS treatment.

Main Methods:

  • Review of current literature on stem cell applications in multiple sclerosis models.
  • Analysis of studies involving transplantation of iPSC-derived neural cells and directly reprogrammed induced neural cells.
  • Evaluation of the efficacy and mechanisms of action of various stem cell types in demyelination and neuroinflammation.

Main Results:

  • Transplantation of iPSC-derived neural cells has shown significant improvements in mobility and robust remyelination in demyelinated models.
  • Direct reprogramming into iNSCs and iOPCs, bypassing pluripotency, has demonstrated effectiveness in models like congenital hypomyelination.
  • Induced stem/progenitor cells exhibit capacity for cell repopulation, immunomodulation, and neurotrophic support.

Conclusions:

  • Induced stem/progenitor cells, including iPSCs, iNSCs, and iOPCs, represent a promising frontier for developing novel MS therapies.
  • Further research and technological advancements are crucial to enhance the efficiency and safety of iPSC-based therapies for MS.
  • Stem cell-based strategies offer a potential pathway to address the challenges posed by degenerative and inflammatory neurological conditions like MS.